Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-24 @ 4:46 PM
Ignite Modification Date:
2025-12-24 @ 4:46 PM
NCT ID:
NCT02977650
Brief Summary:
To evaluate the feasibility of EUS-FNA for patients taking anticoagulants without heparin bridge.
Study:
NCT02977650
Study Brief:
Protocol Section:
NCT02977650